Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2025-12-27 @ 10:19 PM
Study NCT ID:
NCT07023861
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-17
First Post:
2025-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Sponsor:
Affiliated Hospital of Jiangnan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LS2024583
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None